UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

670P Discordant pathologic tumor response in primary tumors and lymph nodes after neoadjuvant immune checkpoint inhibition (ICI) in head and neck squamous cell carcinoma (HNSCC)

Annals of oncology, 2022-09, Vol.33, p.S849

2022

Link zum Volltext

Verfügbarkeit prüfen

672P Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results on efficacy and correlative analysis

Annals of oncology, 2022-09, Vol.33, p.S850

2022

Link zum Volltext

Verfügbarkeit prüfen

770P Comprehensive immune profiling of primary tumors, lymph nodes, and peripheral blood after treatment with nivolumab and BMS 986205 in head and neck squamous cell carcinoma (HNSCC)

Annals of oncology, 2022-09, Vol.33, p.S893-S894

2022

Link zum Volltext

Verfügbarkeit prüfen

Transcriptome signatures of treatment responses in a preoperative window of opportunity trial of nivolumab and tadalafil in resectable squamous cell carcinoma of the head and neck

Annals of oncology, 2019-10, Vol.30, p.v459

2019

Link zum Volltext

Verfügbarkeit prüfen

1131P - Transcriptome signatures of treatment responses in a preoperative window of opportunity trial of nivolumab and tadalafil in resectable squamous cell carcinoma of the head and neck

Annals of oncology, 2019-10, Vol.30, p.v459-v459

2019

Link zum Volltext

Verfügbarkeit prüfen

1205P - Immune correlates in peripheral blood samples in a preoperative window of opportunity randomized trial of nivolumab with or without tadalafil in resectable squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2019-10, Vol.30, p.v493-v493

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune correlates in peripheral blood samples in a preoperative window of opportunity randomized trial of nivolumab with or without tadalafil in resectable squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2019-10, Vol.30, p.v493

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment Implications for Complete Pathologic Responders to Neoadjuvant Immunotherapy

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e25-e25

2022

Link zum Volltext

Verfügbarkeit prüfen

Stable Reconstitution of Gasdermin-E in a Gasdermin-E-Deficient Head and Neck Squamous Cell Carcinoma Mouse Cell Line Enhances Pyroptosis-Mediated Release of Tumor Immunogenic Molecules

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e47-e47

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral Squamous Cell Carcinoma in Young Patients–A Case-Control Analysis

International journal of radiation oncology, biology, physics, 2018-04, Vol.100 (5), p.1356-1357

2018

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Method to Increase Enrollment in Head and Neck Cancer Clinical Trials

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1157-1157

2020

Link zum Volltext

Verfügbarkeit prüfen

Head and Neck Surgery Global Outreach Amongst AHNS Members: Ethics, Planning, and Impact

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1159-1160

2020

Link zum Volltext

Verfügbarkeit prüfen

869P Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results of a pilot study

Annals of oncology, 2021-09, Vol.32, p.S791-S791

2021

Link zum Volltext

Verfügbarkeit prüfen

689P Effects of durvalumab-metformin on head and neck squamous cell carcinoma (HNSCC) as revealed by digital spatial profiling (DSP)

Annals of oncology, 2022-09, Vol.33, p.S858

2022

Link zum Volltext

Verfügbarkeit prüfen

Survival Following Photoimmunotherapy in Patients (Pts) with Recurrent Head and Neck Squamous Cell Carcinoma (rHNSCC)

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1180-1180

2020

Link zum Volltext

Verfügbarkeit prüfen

1129P - Window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN): Interim safety analysis

Annals of oncology, 2019-10, Vol.30, p.v458-v458

2019

Link zum Volltext

Verfügbarkeit prüfen

Window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN): Interim safety analysis

Annals of oncology, 2019-10, Vol.30, p.v458

2019

Link zum Volltext

Verfügbarkeit prüfen

1116PD - A window of opportunity trial of preoperative nivolumab with or without tadalafil in squamous cell carcinoma of the head and neck (SCCHN): Safety, clinical, and correlative outcomes

Annals of oncology, 2019-10, Vol.30, p.v453-v453

2019

Link zum Volltext

Verfügbarkeit prüfen

A window of opportunity trial of preoperative nivolumab with or without tadalafil in squamous cell carcinoma of the head and neck (SCCHN): Safety, clinical, and correlative outcomes

Annals of oncology, 2019-10, Vol.30, p.v453

2019

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab and Ipilimumab Combined with Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: In-field Toxicity Analysis of a Phase I Clinical Trial

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.S106-S107

2020

Link zum Volltext

Verfügbarkeit prüfen

MUC1 regulates PDGFA expression during pancreatic cancer progression

Oncogene, 2012-11, Vol.31 (47), p.4935-4945

2012

Link zum Volltext

Verfügbarkeit prüfen

Differential Activation of Cancer-Associated Fibroblasts in HPV-Associated Head and Neck Squamous Cell Carcinoma Patients Detected Using Spatial Transcriptomics

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e35-e36

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of NCCN Guideline Adherence in Elderly Head and Neck Cancer Patients: A Single Institution Study

International journal of radiation oncology, biology, physics, 2018-04, Vol.100 (5), p.1392-1392

2018

Link zum Volltext

Verfügbarkeit prüfen

Continuous Remote Activity Monitoring In Head And Neck Cancer Patients Receiving Radiotherapy: An Initial Report On Patient Compliance And Utility From A Phase I Trial

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e774-e775

2020

Link zum Volltext

Verfügbarkeit prüfen

923P Immune alterations in a window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2020-09, Vol.31, p.S665-S666

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(91)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(15)
Humans
(13)
Male
(9)
Physical Sciences
(9)
Female
(7)
Exact Sciences And Technology
(6)
Adult
(5)
Biological And Medical Sciences
(5)
Child
(5)
Physics
(5)
Social Sciences
(5)
Technology
(5)
Wass
(5)
Aged
(4)
Bgi / Prodig
(4)
Earth, Ocean, Space
(4)
Engineering
(4)
Engineering, Electrical & Electronic
(4)
Geography
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

670P Discordant pathologic tumor response in primary tumors and lymph nodes after neoadjuvant immune checkpoint inhibition (ICI) in head and neck squamous cell carcinoma (HNSCC)

672P Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results on efficacy and correlative analysis

770P Comprehensive immune profiling of primary tumors, lymph nodes, and peripheral blood after treatment with nivolumab and BMS 986205 in head and neck squamous cell carcinoma (HNSCC)

Transcriptome signatures of treatment responses in a preoperative window of opportunity trial of nivolumab and tadalafil in resectable squamous cell carcinoma of the head and neck

1131P - Transcriptome signatures of treatment responses in a preoperative window of opportunity trial of nivolumab and tadalafil in resectable squamous cell carcinoma of the head and neck

1205P - Immune correlates in peripheral blood samples in a preoperative window of opportunity randomized trial of nivolumab with or without tadalafil in resectable squamous cell carcinoma of the head and neck (SCCHN)

Immune correlates in peripheral blood samples in a preoperative window of opportunity randomized trial of nivolumab with or without tadalafil in resectable squamous cell carcinoma of the head and neck (SCCHN)

Treatment Implications for Complete Pathologic Responders to Neoadjuvant Immunotherapy

Stable Reconstitution of Gasdermin-E in a Gasdermin-E-Deficient Head and Neck Squamous Cell Carcinoma Mouse Cell Line Enhances Pyroptosis-Mediated Release of Tumor Immunogenic Molecules

Oral Squamous Cell Carcinoma in Young Patients–A Case-Control Analysis

A Systematic Method to Increase Enrollment in Head and Neck Cancer Clinical Trials

Head and Neck Surgery Global Outreach Amongst AHNS Members: Ethics, Planning, and Impact

869P Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results of a pilot study

689P Effects of durvalumab-metformin on head and neck squamous cell carcinoma (HNSCC) as revealed by digital spatial profiling (DSP)

Survival Following Photoimmunotherapy in Patients (Pts) with Recurrent Head and Neck Squamous Cell Carcinoma (rHNSCC)

1129P - Window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN): Interim safety analysis

Window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN): Interim safety analysis

1116PD - A window of opportunity trial of preoperative nivolumab with or without tadalafil in squamous cell carcinoma of the head and neck (SCCHN): Safety, clinical, and correlative outcomes

A window of opportunity trial of preoperative nivolumab with or without tadalafil in squamous cell carcinoma of the head and neck (SCCHN): Safety, clinical, and correlative outcomes

Nivolumab and Ipilimumab Combined with Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: In-field Toxicity Analysis of a Phase I Clinical Trial

MUC1 regulates PDGFA expression during pancreatic cancer progression

Differential Activation of Cancer-Associated Fibroblasts in HPV-Associated Head and Neck Squamous Cell Carcinoma Patients Detected Using Spatial Transcriptomics

Evaluation of NCCN Guideline Adherence in Elderly Head and Neck Cancer Patients: A Single Institution Study

Continuous Remote Activity Monitoring In Head And Neck Cancer Patients Receiving Radiotherapy: An Initial Report On Patient Compliance And Utility From A Phase I Trial

923P Immune alterations in a window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN)

Suchergebnisse filtern